|Other Names||Type 2 lactosamine alpha-2, 3-sialyltransferase, 2499-, CMP-NeuAc:beta-galactoside alpha-2, 3-sialyltransferase VI, ST3Gal VI, ST3GalVI, Sialyltransferase 10, ST3GAL6, SIAT10|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Involved in the synthesis of sialyl-paragloboside, a precursor of sialyl-Lewis X determinant. Has a alpha-2,3- sialyltransferase activity toward Gal-beta1,4-GlcNAc structure on glycoproteins and glycolipids. Has a restricted substrate specificity, it utilizes Gal-beta1,4-GlcNAc on glycoproteins, and neolactotetraosylceramide and neolactohexaosylceramide, but not lactotetraosylceramide, lactosylceramide or asialo-GM1.|
|Cellular Location||Golgi apparatus membrane; Single-pass type II membrane protein|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Sialyltransferases, such as ST3GAL6, catalyze the transfer of sialic acid from cytidine 5-prime monophospho-N-acetylneuraminic acid (CMP-NeuAc) to terminal positions of glycoprotein and glycolipid carbohydrate groups. Terminal NeuAc residues are key determinants of carbohydrate structures, such as the sialyl-Lewis X determinants, and are widely distributed in many cell types.
Carvalho, A.S., et al. Int. J. Biochem. Cell Biol. 42(1):80-89(2010)Kawamura, Y.I., et al. Gastroenterology 135(1):142-151(2008)Okajima, T., et al. J. Biol. Chem. 274(17):11479-11486(1999)
If you have any additional inquiries please email technical services at email@example.com.